AMPH Amphastar Pharmaceuticals
- 42.440
- +1.140+2.76%
- 42.440
- 0.0000.00%
Amphastar Pharmaceuticals News
Amphastar Pharmaceuticals | 10-Q: Quarterly report
Amphastar Pharmaceuticals | 8-K: Current report
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Petersen Floyd F.
Amphastar Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Amphastar Pharmaceuticals | DEFA14A: Others
Amphastar Pharmaceuticals | ARS: Annual Report to Security Holders
Amphastar Pharmaceuticals | DEFA14A: Others
Amphastar Pharmaceuticals | DEF 14A: Definitive information statements
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Petersen Floyd F.
Amphastar Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zhang Jack Y.
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Liawatidewi Yakob
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zhou Rong
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer PETERS WILLIAM J
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer PETERS WILLIAM J
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Liawatidewi Yakob
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zhou Rong
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zhang Jack Y.
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zhang Jack Y.
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director ZASLOFF MICHAEL A
Analysis
Price Target
No Data
